For: | Gibson BG, Cox TE, Marchbank KJ. Contribution of animal models to the mechanistic understanding of Alternative Pathway and Amplification Loop (AP/AL)-driven Complement-mediated Diseases. Immunol Rev 2023;313:194-216. [PMID: 36203396 DOI: 10.1111/imr.13141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Dreismann AK, Hallam TM, Tam LC, Nguyen CV, Hughes JP, Ellis S, Harris CL. Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway. Immunol Rev 2023;313:402-19. [PMID: 36369963 DOI: 10.1111/imr.13149] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
2 | Harrison RA, Harris CL, Thurman JM. The complement alternative pathway in health and disease-activation or amplification? Immunol Rev 2023;313:6-14. [PMID: 36424888 DOI: 10.1111/imr.13172] [Reference Citation Analysis] |